Ares Financial Consulting’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-24
Closed -$300 – 1115
2026
Q2
$300 Buy
+24
New +$321 ﹤0.01% 1108

Other funds holding OLMA

Ares Financial Consulting's OLMA Position: Q3 2026 in Review

Ares Financial Consulting sold out of Olema Oncology (OLMA) in Q3 2026, closing a stake of 24 shares — an estimated $300 sold.

Ares Financial Consulting first reported a position in OLMA in Q2 2026 and held it in 1 quarter. The position peaked at $300 in Q2 2026. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Ares Financial Consulting reported no remaining Olema Oncology position as of Q3 2026 after selling out during the quarter.
  • Ares Financial Consulting sold 24 Olema Oncology shares in Q3 2026, an estimated $300.
  • Ares Financial Consulting first reported a position in Olema Oncology in Q2 2026 and held it in 1 quarter.
  • Ares Financial Consulting's Olema Oncology position peaked at $300 in Q2 2026.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.